BIIB Competitors
Biogen Inc.
$248.35
+$4.42(+1.81%)
67
Overall
80
Value
75
Tech
47
Quality
Market Cap
$36.71B
Volume
1.00M
52W Range
$153.77 - $258.78
Target Price
$263.81
BIIB competitors: AMGN, GILD, ABBV, PFE, JNJ. Biogen Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
BIIB Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| AMGN Amgen Inc. | $460.42 | $249.05B | $23.46 | 2.16% | 77 |
| GILD Gilead Sciences, Inc. | $166.89 | $207.00B | $-0.98 | 1.95% | 80 |
| ABBV AbbVie Inc. | $291.31 | $514.92B | $13.99 | 2.38% | 67 |
| PFE Pfizer Inc. | $29.39 | $167.52B | $3.01 | 4.39% | 79 |
| JNJ Johnson & Johnson | $276.22 | $664.95B | $11.12 | 1.91% | 70 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BIIB | $248.35 | +1.8% | 1.00M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |